{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:34Z","timestamp":1786979614738,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00108-016-0026-x","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T02:36:54Z","timestamp":1455676614000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmakotherapie der Harninkontinenz im Alter","Pharmacotherapy of urinary incontinence in the elderly"],"prefix":"10.1007","volume":"57","author":[{"given":"K. F.","family":"Becher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"issue":"1","key":"26_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/ICU.0b013e32831bc0ad","volume":"20","author":"S Abdel-Aziz","year":"2009","unstructured":"Abdel-Aziz S, Mamalis N (2009) Intraoperative floppy iris syndrome. Curr Opin Ophthalmol 20(1):37\u201341","journal-title":"Curr Opin Ophthalmol"},{"key":"26_CR2","volume-title":"4th international consultation on incontinence. recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence","author":"P Abrams","year":"2009","unstructured":"Abrams P, Andersson KE, Birder L et al (2009) 4th international consultation on incontinence. recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence 4th International Consultation on Incontinence. Paris"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation sub-committee of the international continence society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"26_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/0970-1591.57917","volume":"25","author":"MS Agrawal","year":"2009","unstructured":"Agrawal MS, Yadav A, Yadav H, Singh AK, Lavania P, Jaiman R (2009) A prospective randomized study comparing alfuzosin and tamsulosin in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia. Indian J Urol 25(4):474\u2013478","journal-title":"Indian J Urol"},{"issue":"7539","key":"26_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","volume":"332","author":"ML Ancelin","year":"2006","unstructured":"Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K (2006) Non\u00acdegenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332(7539):455\u2013459","journal-title":"BMJ"},{"key":"26_CR6","volume-title":"S1-Leitlinie Harninkontinenz","author":"K Becher","year":"2015","unstructured":"Becher K, Bojak B, Kirschner-Hermanns R (2015) S1-Leitlinie Harninkontinenz (AWMF-Register Nr.\u00a0084\/001; Basisassessment, Stand 12.10.2015)"},{"issue":"3","key":"26_CR7","first-page":"178","volume":"13","author":"KK Bhomi","year":"2011","unstructured":"Bhomi KK, Bhattachan CL (2011) Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Nepal Med Coll J 13(3):178\u2013181","journal-title":"Nepal Med Coll J"},{"issue":"7","key":"26_CR8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1532-5415.2000.tb04744.x","volume":"48","author":"JS Brown","year":"2000","unstructured":"Brown JS, Vittinghoff E, Wyman JF et al (2000) Urinary incontinence: does it increase risk for falls and fractures? study of Osteoporotic fractures research group. J Am Geriatr Soc 48(7):721\u2013725","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"26_CR9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1345\/aph.1K679","volume":"42","author":"MA Cantrell","year":"2008","unstructured":"Cantrell MA, Bream-Rouwenhorst HR, Steffensmeier A, Hemerson P, Rogers M, Stamper B (2008) Intraoperative floppy iris syndrome associated with alpha1-adrenergic receptor antagonists. Ann Pharmacother 42(4):558\u2013563","journal-title":"Ann Pharmacother"},{"issue":"7","key":"26_CR10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jcrs.2008.04.014","volume":"34","author":"DF Chang","year":"2008","unstructured":"Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD et al (2008) Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey. J Cataract Refract Surg 34(7):1201\u20131209","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"26_CR11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eururo.2012.10.048","volume":"63","author":"CR Chapple","year":"2013","unstructured":"Chapple CR, Kaplan SA, Mitcheson D, Klecka J, Cummings J, Drogendijk T et al (2013) Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a beta(3)-adrenoceptoragonist in overactive bladder. Eur Urol 63(2):296\u2013305","journal-title":"Eur Urol"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","volume":"54","author":"CR Chapple","year":"2008","unstructured":"Chapple CR, Khullar V, Gabriel Z et al (2008) The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 54:543\u2013562","journal-title":"Eur Urol"},{"key":"26_CR13","first-page":"CD001405","volume":"2009","author":"JD Cody","year":"2009","unstructured":"Cody JD, Richardson K, Moehrer B et al (2009) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2009:CD001405","journal-title":"Cochrane Database Syst Rev"},{"issue":"4 Pt 1","key":"26_CR14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/01.ju.0000080708.87092.cc","volume":"170","author":"RR Dmochowski","year":"2003","unstructured":"Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 170(4 Pt 1):1259\u20131263","journal-title":"J Urol"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.juro.2013.08.027","volume":"191","author":"CE DuBeau","year":"2014","unstructured":"DuBeau CE, Kraus SR, Griebling TL, Newman DK, Wyman JF, Johnson TM 2nd, Ouslander JG, Sun F, Gong J, Bavendam T (2014) Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol 191:395\u2013404","journal-title":"J Urol"},{"issue":"5","key":"26_CR16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/01.ju.0000154167.90600.c6","volume":"173","author":"GM Ghoniem","year":"2005","unstructured":"Ghoniem GM, Van Leeuwen JS, Elser DM, Freeman RM, Zhao YD, Yalcin I et al (2005) A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol 173(5):1647\u20131653","journal-title":"J Urol"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0302-2838(02)00014-3","volume":"41","author":"M Goepel","year":"2002","unstructured":"Goepel M, Hoffmann JA, Piro M, R\u00fcbgen H, Michal MC (2002) Prevalence and Physician awareness of symptoms of urinary bladder dysfunction. Eur Urol 41:234\u2013239","journal-title":"Eur Urol"},{"issue":"1","key":"26_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1067\/mob.2001.116371","volume":"185","author":"MA Harvey","year":"2001","unstructured":"Harvey MA, Baker K, Wells GA (2001) Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Am J Obstet Gynecol 185(1):56\u201361","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2006.03.057","volume":"50","author":"G Kay","year":"2006","unstructured":"Kay G, Crook T, Rekeda L et al (2006) Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 50:317\u2013326","journal-title":"Eur Urol"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","volume":"63","author":"V Khullar","year":"2013","unstructured":"Khullar V, Amarenco G, Angulo JC et al (2013) Efficacy and tolerability of mirabegron, a \u03b2(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol 63:283\u2013295","journal-title":"Eur Urol"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2490-13-45","volume":"13","author":"V Khullar","year":"2013","unstructured":"Khullar V, Cambronero J, Angulo JC, Wooning M, Blauwet MB, Dorrepaal C et al (2013) Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial. BMC Urol 13:45","journal-title":"BMC Urol"},{"issue":"4","key":"26_CR22","first-page":"256","volume":"7","author":"HL Kim","year":"2001","unstructured":"Kim HL, Kim JC, Benson DA, Bales GT, Gerber GS (2001) Results of treatment with tamsulosin in men with acute urinary retention. Tech Urol 7(4):256\u2013260","journal-title":"Tech Urol"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.eururo.2012.08.047","volume":"62","author":"MG Lucas","year":"2012","unstructured":"Lucas MG, Bosch RJL, Burkhard FC et al (2012) EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol 62:1130\u20131142","journal-title":"Eur Urol"},{"issue":"3","key":"26_CR24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-410X.2005.05299.x","volume":"95","author":"MG Lucas","year":"2005","unstructured":"Lucas MG, Stephenson TP, Nargund V (2005) Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int 95(3):354\u2013357","journal-title":"BJU Int"},{"issue":"8","key":"26_CR25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/ijcp.12433","volume":"68","author":"VW Nitti","year":"2014","unstructured":"Nitti VW, Chapple CR, Walters C, Blauwet MB, Herschorn S, Milsom I et al (2014) Safety and tolerability of the beta3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1\u2011year randomised Phase III trial. Int J Clin Pract 68(8):972\u2013985","journal-title":"Int J Clin Pract"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","volume":"189","author":"VW Nitti","year":"2013","unstructured":"Nitti VW, Dmochowski R, Herschorn S et al (2013) Onabotulinumtoxin A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol 189:2186\u20132193","journal-title":"J Urol"},{"issue":"4","key":"26_CR27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.juro.2013.05.062","volume":"190","author":"VW Nitti","year":"2013","unstructured":"Nitti VW, Rosenberg S, Mitcheson DH, He W, Fakhoury A, Martin NE (2013) Urodynamics and safety of the beta(3)-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol 190(4):1320\u20131327","journal-title":"J Urol"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.ju.0000067621.62736.7c","volume":"170","author":"M Nomiya","year":"2003","unstructured":"Nomiya M, Yamaguchi O (2003) A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649\u2013653","journal-title":"J Urol"},{"issue":"1","key":"26_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mob.2002.124840","volume":"187","author":"PA Norton","year":"2002","unstructured":"Norton PA, Zinner NR, Yalcin I, Bump RC (2002) Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187(1):40\u201348","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"26_CR30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/jop.2012.0254","volume":"29","author":"GD Novack","year":"2013","unstructured":"Novack GD, Lewis RA, Vogel R, Sheth N, Swearingen D, Rasmussen S et al (2013) Randomized, double-masked, placebo-controlled study to assess the ocular safety of mirabegron in healthy volunteers. J Ocul Pharmacol Ther 29(7):674\u2013680","journal-title":"J Ocul Pharmacol Ther"},{"key":"26_CR31","author":"M Oelke","year":"2015","unstructured":"Oelke M, Becher K, Castro-Diaz D, Chartier-Kastler E, Kirby M, Wagg A, Wehling M (2015) Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014). Age Ageing, doi:10.1093\/ageing\/afv077","journal-title":"Age Ageing"},{"issue":"3","key":"26_CR32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/01443615.2010.547955","volume":"31","author":"R Patel-Gadhia","year":"2011","unstructured":"Patel-Gadhia R, Bhal K, Patil P (2011) Retrospective audit on tolerability and efficacy of duloxetine for stress urinary incontinence. J Obstet Gynaecol 31(3):258\u2013259","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"26_CR33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0749-0690(18)30734-1","volume":"4","author":"NM Resnick","year":"1988","unstructured":"Resnick NM, Baumann MM (1988) Incontinence in the nursing home patient. Clin Geriatr Med 4(3):549\u2013570","journal-title":"Clin Geriatr Med"},{"key":"26_CR34","first-page":"30","volume":"6","author":"PI Rasner","year":"2009","unstructured":"Rasner PI, Pushkar\u2019 DI (2009) Administration of two uroselective alpha-adrenoblockers in pharmacological treatment of acute urinary retention in patients with prostatic adenoma. Urologiia 6:30\u201334","journal-title":"Urologiia"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00120-007-1592-2","volume":"47","author":"C Seif","year":"2008","unstructured":"Seif C, Boy S, Wefer B et al (2008) Botulinumtoxin in der Therapie der \u00fcberaktiven Blase \u2013 ein \u00dcberblick. Urologe 47:46\u201353","journal-title":"Urologe"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1532-5415.2010.02988.x","volume":"58","author":"D Staskin","year":"2010","unstructured":"Staskin D, Kay G, Tannenbaum C et al (2010) Trospium chloride is undetectable in the older human central nervous system. J Am Geriatr Soc 58:1618\u20131619","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"26_CR37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/jop.2012.0151","volume":"29","author":"HA Tufan","year":"2013","unstructured":"Tufan HA, Gencer B, Kara S, Comez AT, Kurt HA, Alan C (2013) Alterations in iris structure and pupil size related to alpha-1 Adrenergic receptor antagonists use: implications for floppy iris syndrome. J Ocul Pharmacol Ther 29(4):410\u2013413. doi:10.1089\/jop.2012.0151 (epub ahead 5. December 2012)","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"26_CR38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1471-0528.2004.00067.x","volume":"111","author":"P Kerrebroeck van","year":"2004","unstructured":"van Kerrebroeck P, Abrams P, Lange R, Slack M, Wyndaele JJ, Yalcin I et al (2004) Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 111(3):249\u2013257","journal-title":"BJOG"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CIA.S25326","volume":"7","author":"AG Vinsnes","year":"2012","unstructured":"Vinsnes AG, Helbostad JL, Nyronning S et al (2012) Effect of physical training on urinary incontinence: a randomized parallel group trial in nursing homes. Clin Interv Aging 7:45\u201350","journal-title":"Clin Interv Aging"},{"issue":"5","key":"26_CR40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ageing\/afu017","volume":"43","author":"A Wagg","year":"2014","unstructured":"Wagg A, Cardozo L, Nitti VW, Castro-Diaz D, Auerbach S, Blauwet MB et al (2014) The efficacy and tolerability of the beta3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age Ageing 43(5):666\u2013675","journal-title":"Age Ageing"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00120-007-1305-x","volume":"46","author":"A Welz-Barth","year":"2007","unstructured":"Welz-Barth A (2007) Inkontinenz im Alter, ein soziales und \u00f6konomisches Problem. Urologe 46:363\u2013364","journal-title":"Urologe"},{"key":"26_CR42","first-page":"131","volume":"6","author":"GF Wolff","year":"2014","unstructured":"Wolff GF, Kuchel GA, Smith PP (2014) Overactive bladder in the vulnerable elderly. Res Rep Urol 6:131\u2013138","journal-title":"Res Rep Urol"},{"issue":"4","key":"26_CR43","first-page":"CD006744","volume":"2009","author":"HJ Zeif","year":"2009","unstructured":"Zeif HJ, Subramonian K (2009) Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. Cochrane Database Syst Rev 2009(4):CD006744","journal-title":"Cochrane Database Syst Rev"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00391-013-0491-y","volume":"46","author":"K Becher","year":"2013","unstructured":"Becher K, Oelke M, Grass-Kapanke B (2013) Improving the health care of geriatric patients: management of urinary incontinence: a position paper. Z Gerontol Geriatr 46:456\u2013464 (Seite\u00a0462) doi:10.1007\/s00391-013-0491-y","journal-title":"Z Gerontol Geriatr"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0026-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-016-0026-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0026-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T13:36:49Z","timestamp":1567604209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-016-0026-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s00108-016-0026-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}